Downregulation of CLU has been shown to induce cellular senescence and inhibit cell proliferation in cancer cells, suggesting that targeting CLU could be a potential therapeutic strategy for gliomas (Mitsufuji et al., 2022). The gene discussed is CLU; the disease is cancer.